KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.30 $3.29 Friday, 26th Apr 2024 ABUS stock ended at $2.73. This is 0.368% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.21% from a day low at $2.71 to a day high of $2.77.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
Apr 11, 2016 $4.72 $4.72 $4.72 $4.72 358 066
Apr 08, 2016 $5.05 $5.05 $5.05 $5.05 917 678
Apr 07, 2016 $5.06 $5.06 $5.06 $5.06 445 667
Apr 06, 2016 $4.70 $4.70 $4.70 $4.70 288 830
Apr 05, 2016 $4.35 $4.35 $4.35 $4.35 152 124
Apr 04, 2016 $4.15 $4.15 $4.15 $4.15 168 930
Apr 01, 2016 $4.17 $4.17 $4.17 $4.17 140 704
Mar 31, 2016 $4.13 $4.13 $4.13 $4.13 141 067
Mar 30, 2016 $3.97 $3.97 $3.97 $3.97 92 787
Mar 29, 2016 $4.09 $4.09 $4.09 $4.09 123 500
Mar 28, 2016 $3.81 $3.81 $3.81 $3.81 135 900
Mar 24, 2016 $3.99 $3.99 $3.99 $3.99 102 600
Mar 23, 2016 $3.89 $3.89 $3.89 $3.89 242 300
Mar 22, 2016 $4.34 $4.34 $4.34 $4.34 196 800
Mar 21, 2016 $4.13 $4.13 $4.13 $4.13 263 400
Mar 18, 2016 $3.96 $3.96 $3.96 $3.96 114 100
Mar 17, 2016 $3.64 $3.64 $3.64 $3.64 131 900
Mar 16, 2016 $3.69 $3.69 $3.69 $3.69 123 400
Mar 15, 2016 $3.69 $3.69 $3.69 $3.69 201 800
Mar 14, 2016 $3.94 $3.94 $3.94 $3.94 156 300
Mar 11, 2016 $3.85 $3.85 $3.85 $3.85 118 900
Mar 10, 2016 $3.74 $3.74 $3.74 $3.74 124 100
Mar 09, 2016 $3.88 $3.88 $3.88 $3.88 214 300
Mar 08, 2016 $3.96 $3.96 $3.96 $3.96 151 400
Mar 07, 2016 $4.01 $4.01 $4.01 $4.01 360 300
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT